The Technical Analyst
Elekta AB (publ) [EKTAY]
Exchange: OTC Sector: Healthcare Industry: Medical Instruments & Supplies
Elekta AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.64% $7.07
America/New_York / 3 mai 2024 @ 15:57
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 693.16 mill |
| EPS: | 0.340 |
| P/E: | 20.79 |
| Earnings Date: | Jun 05, 2024 |
| SharesOutstanding: | 380.93 mill |
| Avg Daily Volume: | 0.0096 mill |
| RATING 2024-05-03 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.72x |
| Company: PE 20.79 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.61x |
| Company: PE 20.79 | industry: PE 34.33 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$3.40 (-51.98%) $-3.67 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
$ 6.91 - 7.23 ( +/- 2.28%) |
| ATR Model: 14 days |
Forecast:
16:00 - $7.07
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $7.07
Forecast 2: 16:00 - $7.07
Forecast 3: 16:00 - $7.07
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $7.07 (0.64% ) |
| Volume | 0.0142 mill |
| Avg. Vol. | 0.0096 mill |
| % of Avg. Vol | 146.78 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For EKTAY
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
EKTAY
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Latest Press Releases
2023-09-28 02:11:00 - Press Release
Zap Surgical Deals Two More Blows To Elekta In Ip Suit, Removing Barriers To Mass Adoption Of The Zap-x Radiosurgery Platform
San carlos, calif.--(business wire)--zap surgical systems, inc., a leading innovator in the field of surgical robotics, has achieved significant legal victories in its ongoing patent litigation against its much larger competitor, elekta, solidifying the continued availability of the groundbreaking zap-x® gyroscopic radiosurgery® platform in global markets. in april 2019, elekta alleged that the zap-x infringed upon its patent 7,296,648, which described a theoretical design for a radiosurgery de.
2021-07-23 01:55:00 - Press Release
Data From 14 Leading Cancer Centers Presented At Aapm Highlight Global Adoption Of Elekta Unity Mr-linac
Atlanta, july 23, 2021 /prnewswire/ -- elekta (ekta-b.st) today announced the presentation of 36 abstracts demonstrating the technical capabilities and clinical utility of the elekta unity mr-linac. the research described in the abstracts was conducted at 14 leading cancer centers in north america, europe, asia and australia, reflecting the broad global adoption of the system.
2021-07-21 02:41:00 - Press Release
Notice To The Annual General Meeting Of Elekta Ab (publ)
Stockholm, july 21, 2021 /prnewswire/ -- the shareholders of elekta ab (publ), reg. no 556170-4015 are hereby convened to the annual general meeting to be held on wednesday 25 august 2021.
2021-07-07 01:56:00 - Press Release
Elekta Optimizes Treatment Times For Cancer Patients Via Proactive Service Innovation
Stockholm, july 7, 2021 /prnewswire/ -- for the last several years, elekta (ekta-b.st) has invested substantially in digitized service solutions to keep critical treatment machines up and running at cancer clinics, thereby ensuring that patients receive timely radiotherapy. among these solutions is the remote exchange of technical system data between elekta remote service centers and linear accelerators installed at hospitals worldwide.
2021-06-07 03:43:00 - Press Release
Elekta And Philips Deepen Strategic Partnership In Precise And Individualized Oncology Care
Stockholm and amsterdam, june 7, 2021 /prnewswire/ -- elekta (ekta-b.st) and royal philips (nyse: phg, aex: phia) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. the extended collaboration builds on the two companies' successful cooperation in the fast-emerging field of magnetic resonance (mr)-guided adaptive radiation therapy.
Latest News
2024-05-01 10:46:34 - Zacks Investment Research
Are Investors Undervaluing Elekta (EKTAY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
2024-04-15 10:46:10 - Zacks Investment Research
Is Elekta (EKTAY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
2024-03-28 10:41:07 - Zacks Investment Research
Should Value Investors Buy Elekta (EKTAY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
2024-03-08 10:46:13 - Zacks Investment Research
Are Investors Undervaluing Elekta (EKTAY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
2024-02-20 10:46:14 - Zacks Investment Research
Is Elekta (EKTAY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
2023-12-07 11:18:04 - Zacks Investment Research
Is Elekta (EKTAY) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
2023-11-30 16:46:04 - Seeking Alpha
Elekta AB (EKTAF) Q2 2024 Earnings Call Transcript
Elekta AB (OTCPK:EKTAF) Q2 2024 Earnings Conference Call November 30, 2023 4:00 AM ET Company Participants Cecilia Ketels - Head, IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Conference Call Participants Mattias Vadsten - SEB Oliver Reinberg - Kepler Cheuvreux Kristofer Liljeberg - Carnegie Hassan Al-Wakeel - Barclays Rickard Anderkrans - Handelsbanken Lisa Clive - Bernstein Veronika Dubajova - Citi Robert Davies - Morgan Stanley Cecilia Ketels Good morning, everyone, and warm welcome to the presentation of Elekta's Second Quarter 2023-'24. My name is Cecilia Ketels, and I'm Head of Investor Relations at Elekta.
2023-02-24 10:54:05 - Seeking Alpha
Elekta AB (publ) (EKTAF) Q3 2023 Earnings Call Transcript
Elekta AB (publ) (OTCPK:EKTAF) Q3 2023 Earnings Conference Call February 24, 2023 4:00 AM ET Company Participants Cecilia Ketels - Head of Investor Relations Gustaf Salford - President & Chief Executive Officer Tobias Hagglov - Chief Financial Officer Conference Call Participants Mattias Vadsten - SEB Erik Cassel - ABG Oliver Reinberg - Kepler Cheuvreux Rickard Anderkrans - Handelsbanken Julien Ouaddour - Bank of America David Adlington - JPMorgan Robert Davies - Morgan Stanley Cecilia Ketels Good morning, everyone, and warm welcome to the presentation of Elekta's Third Quarter 2022-2023. My name is Cecilia Ketels, and I'm Head of Investor Relations at Elekta.
2022-11-24 08:50:03 - Seeking Alpha
Elekta AB (publ) (EKTAF) Q2 2023 Earnings Call Transcript
Elekta AB (publ) (OTCPK:EKTAF) Q2 2023 Results Conference Call November 24, 2022 12:00 PM ET Company Participants Cecilia Ketels - Head of IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Conference Call Participants Erik Cassel - ABG Sundal Collier Mattias Vadsten - SEB Kristofer Liljeberg - Carnegie Robert Davies - Morgan Stanley Victor Forssell - Nordea Julien Ouaddour - Bank of America Oliver Reinberg - Kepler Cheuvreux Rickard Anderkrans - Handelsbanken David Adlington - JPMorgan Veronika Dubajova - Citi Cecilia Ketels Good morning, everyone, and warm welcome to the presentation of Elekta's Second Quarter 2022-23. My name is Cecilia Ketels, and I'm the Head of Investor Relations at Elekta.
2022-08-25 15:55:25 - Seeking Alpha
Elekta AB (publ) (EKTAF) Q1 2023 Earnings Call Transcript
Elekta AB (publ) (OTCPK:EKTAF) Q1 2023 Earnings Conference Call August 25, 2022 4:00 AM ET Company Participants Cecilia Ketels - Head of IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Conference Call Participants Erik Cassel - ABG Sundal Collier Kristofer Liljeberg - Carnegie Victor Forssell - Nordea Veronika Dubajova - Citi Rickard Anderkrans - Handelsbanken David Adlington - JPMorgan Cecilia Ketels Good morning, everyone, and warm welcome to the presentation of Elekta's First Quarter 2022/'23. My name is Cecilia Ketels, and I'm Head of Investor Relations at Elekta.